Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Operating Margin
Shanghai HeartCare Medical Technology Corp Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
|
1B HKD |
-5%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.4B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.5B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
141.5B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.9B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53.2B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
29%
|
Shanghai HeartCare Medical Technology Corp Ltd
Glance View
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Shanghai HeartCare Medical Technology Corp Ltd's most recent financial statements, the company has Operating Margin of -5.3%.
You don't have any saved screeners yet